Get started
Award

82272390

Funded outputs count: 8
Funder award ID: 82272390
OpenAlex ID: G1663244199
Integrating single-cell analysis and machine learning algorithms to explore lactylation-related molecular mechanisms and therapeutic responses in clear cell renal cell carcinoma and identifying CDT1 as a potential biomarker
2026 · Yue Zhang, Hang Zhou, et al. · Frontiers in Endocrinology
PDF
The role of RNA modifications in the pathological mechanisms and therapeutic targeting of multiple myeloma
2026 · Hao Chen, Hefei Ren, et al. · Molecular and Cellular Probes · 1
An LC-MS/MS Method for Simultaneous Determination of Almonertinib and Atorvastatin: Evaluating Their Drug-Drug Interactions in Rat
2026 · Huanchen Li, Hongkun Wu, et al. · Drug Design Development and Therapy
Prognostic significance of hematological parameters and albumin in BCMA-targeted CAR-T therapy for multiple myeloma
2025 · Liansheng Jiang, Hefei Ren, et al. · Frontiers in Immunology · 1
PDF
DEK facilitates bortezomib resistance of multiple myeloma by modulating ferroptosis
2025 · Huiquan Wang, Jiafeng Zhang, et al. · Clinical and Experimental Medicine · 3
PDF
Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study
2025 · Jiafeng Zhang, Hefei Ren, et al. · Frontiers in Oncology · 3
PDF
The AKR1C1–CYP1B1–cAMP signaling axis controls tumorigenicity and ferroptosis susceptibility of extrahepatic cholangiocarcinoma
2024 · Chang Liu, Cheng Zhang, et al. · Cell Death and Differentiation · 22
PDF
Is Shigella an under-recognized pathogen? A case of pyogenic cervical spondylitis caused by Escherichia coli and Shigella flexneri infection
2024 · Jiafeng Zhang, Yaoting Liu, et al. · IDCases · 4
Year
Topic